Sign in

CIK 0001395937

  • Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320162505
Phone
+1 781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2018-05-23 Chen Henry Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2018-02-08 Chen Henry Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-05-17 Chen Henry Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-05-17 Chen Henry Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2016-10-31 Chen Henry Director Grant or award · Stock Options (Right to buy) +8,000 8,000

Page 1 of 1 · 5 trades